Provided by Tiger Fintech (Singapore) Pte. Ltd.

Arcutis Biotherapeutics Inc.

14.24
-0.1300-0.90%
Volume:720.76K
Turnover:10.30M
Market Cap:1.70B
PE:-13.69
High:14.85
Open:14.70
Low:14.09
Close:14.37
Loading ...

Officer Patrick Burnett Reports Disposal of Arcutis Biotherapeutics Inc. Common Shares

Reuters
·
10 May

Arcutis Biotherapeutics Reports Strong Q1 Earnings Growth

TIPRANKS
·
08 May

Arcutis Biotherapeutics Files Initial Ownership Statement for SVP CFO Latha Vairavan

Reuters
·
08 May

Arcutis Biotherapeutics Inc. Releases Transcript of Q1 2025 Earnings Conference Call

Reuters
·
08 May

Arcutis Biotherapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
07 May

Stock Track | Arcutis Biotherapeutics Plunges 8.38% After Hours on Q1 Operating Loss and High Expenses

Stock Track
·
07 May

Arcutis Biotherapeutics Q1 EPS $(0.20) Beats $(0.21) Estimate, Sales $65.85M Beat $62.25M Estimate

Benzinga
·
07 May

Stock Track | Arcutis Biotherapeutics Plummets 6.75% as Q1 Operating Income Misses Estimates

Stock Track
·
07 May

Stock Track | Arcutis Biotherapeutics Plummets 6.75% as Q1 Operating Loss Exceeds Estimates

Stock Track
·
07 May

Arcutis Biotherapeutics Inc - Pdufa Action Date for Zoryve Foam Set for May 22, 2025

THOMSON REUTERS
·
07 May

Arcutis Biotherapeutics Q1 Operating Income USD -24.529 Million VS. Ibes Estimate USD -23.9 Million

THOMSON REUTERS
·
07 May

Top Executives Cash Out on Arcutis Biotherapeutics Stock!

TIPRANKS
·
06 May

Director Howard G. Welgus Reports Disposal of Common Shares in Arcutis Biotherapeutics Inc

Reuters
·
06 May

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
03 May

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
03 May

Qiagen (QGEN) Reports Next Week: Wall Street Expects Earnings Growth

Zacks
·
30 Apr

Arcutis Biotherapeutics, Inc. (ARQT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Zacks
·
29 Apr

Is Arcutis Biotherapeutics (ARQT) Stock Outpacing Its Medical Peers This Year?

Zacks
·
24 Apr

Arcutis Biotherapeutics: Buy Rating Affirmed Amid Positive Long-Term Outlook and Strategic Growth Potential

TIPRANKS
·
23 Apr

Arcutis to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025

GlobeNewswire
·
17 Apr